V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20030050 | 20012805 | 1.6 | 83 | Adjuvant (A) | 2017-06-26 | 2017-06-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20105842 | FEC + DOCETAXEL |
| 20030051 | 20012806 | 1.52 | 65.7 | Adjuvant (A) | 2015-11-13 | 2015-11-25 | FEC + DOCETAXEL | N | N | 20105857 | FEC + DOCETAXEL |
| 20030052 | 20012807 | 1.7 | 53.8 | Adjuvant (A) | 2014-01-31 | 2014-02-01 | FEC 100 + DOCETAXEL | 2 | N | 20105864 | FEC + DOCETAXEL |
| 20030053 | 20012807 | 1.61 | 81 | Adjuvant (A) | 2016-12-23 | 2017-01-17 | FEC + DOCETAXEL | 02 | N | 20105864 | FEC + DOCETAXEL |
| 20030054 | 20012808 | 1.68 | null | Neo-adjuvant (N) | 2014-04-03 | 2014-04-22 | FEC 100 + DOCETAXEL | 2 | N | 20105872 | FEC + DOCETAXEL |
| 20030055 | 20012809 | 1.69 | 69.1 | Curative (C) | 2015-01-15 | 2015-01-20 | FEC + DOCETAXEL | 2 | N | 20105874 | FEC + DOCETAXEL |
| 20030056 | 20012809 | 1.7 | 79.2 | Not known (9) | 2013-09-09 | 2013-09-23 | FEC + DOCETAXEL | N | N | 20105874 | FEC + DOCETAXEL |
| 20030057 | 20012810 | null | null | Adjuvant (A) | 2015-04-04 | 2015-04-29 | FEC + DOCETAXEL | 2 | N | 20105884 | FEC + DOCETAXEL |
| 20030058 | 20012811 | 1.69 | 74.5 | Adjuvant (A) | 2015-03-14 | 2015-03-15 | FEC 100 + DOCETAXEL | 2 | N | 20105885 | FEC + DOCETAXEL |
| 20030059 | 20012811 | 1.63 | 83.1 | Adjuvant (A) | 2016-01-31 | 2016-02-05 | FEC + DOCETAXEL | 02 | N | 20105885 | FEC + DOCETAXEL |
| 20030060 | 20012811 | 1.62 | 66.1 | Neo-adjuvant (N) | 2016-05-29 | 2016-05-31 | FEC + DOCETAXEL | 02 | N | 20105885 | FEC + DOCETAXEL |
| 20030061 | 20012812 | null | 75.3 | null | 2014-11-13 | 2014-11-30 | FEC + DOCETAXEL | N | N | 20105896 | FEC + DOCETAXEL |
| 20030062 | 20072742 | 1.75 | null | Neo-adjuvant (N) | 2014-07-05 | 2014-07-07 | FEC + DOCETAXEL | N | null | 20105902 | FEC + DOCETAXEL |
| 20030063 | 20012813 | 1.64 | null | Adjuvant (A) | 2013-08-30 | 2013-12-06 | FEC + DOCETAXEL | 2 | N | 20105905 | FEC + DOCETAXEL |
| 20030064 | 20012813 | 1.58 | null | Adjuvant (A) | null | 2017-01-17 | FEC + DOCETAXEL | N | N | 20105905 | FEC + DOCETAXEL |
| 20030065 | 20012814 | 1.6 | 75 | Curative (C) | 2017-11-13 | 2017-11-18 | FEC + DOCETAXEL | 02 | N | 20105910 | FEC + DOCETAXEL |
| 20030066 | 20012815 | 1.52 | 64 | Adjuvant (A) | 2017-07-15 | 2017-07-22 | FEC + DOCETAXEL | 2 | N | 20105912 | FEC + DOCETAXEL |
| 20030067 | 20012815 | 1.63 | 99 | Adjuvant (A) | 2017-04-05 | 2017-04-20 | FEC + DOCETAXEL | 02 | null | 20105912 | FEC + DOCETAXEL |
| 20030068 | 20012815 | 1.43 | 67 | Adjuvant (A) | null | 2014-01-28 | FEC + DOCETAXEL | N | N | 20105912 | FEC + DOCETAXEL |
| 20030069 | 20012815 | null | null | Neo-adjuvant (N) | 2016-05-23 | 2016-06-03 | FEC + DOCETAXEL | N | null | 20105912 | FEC + DOCETAXEL |
| 20030070 | 20012816 | 1.58 | 87.1 | Neo-adjuvant (N) | 2014-06-01 | 2014-06-24 | FEC 100 + DOCETAXEL | N | N | 20105917 | FEC + DOCETAXEL |
| 20030071 | 20012816 | 1.55 | 63.1 | Not known (9) | 2016-08-06 | 2016-08-15 | FEC + DOCETAXEL | 2 | N | 20105917 | FEC + DOCETAXEL |
| 20030072 | 20012817 | 1.61 | 68.4 | Not known (9) | 2017-02-23 | 2017-03-02 | FEC 100 + DOCETAXEL | 02 | N | 20105926 | FEC + DOCETAXEL |
| 20030073 | 20012817 | 1.75 | 70 | Adjuvant (A) | 2014-06-15 | 2014-06-22 | FEC + DOCETAXEL | 02 | N | 20105926 | FEC + DOCETAXEL |
| 20030075 | 20012819 | 1.52 | null | Adjuvant (A) | 2016-06-26 | 2016-07-12 | FEC 100 + DOCETAXEL | 2 | N | 20105933 | FEC + DOCETAXEL |
| 20030076 | 20012820 | null | 69.8 | Adjuvant (A) | 2017-09-21 | 2017-09-21 | FEC + DOCETAXEL | N | N | 20105937 | FEC + DOCETAXEL |
| 20030077 | 20012821 | 1.61 | 80.4 | Adjuvant (A) | 2014-10-29 | 2014-11-02 | FEC + DOCETAXEL | 02 | N | 20105944 | FEC + DOCETAXEL |
| 20030078 | 20012822 | 1.7 | 78.6 | Adjuvant (A) | 2017-05-31 | 2017-06-08 | FEC + DOCETAXEL | N | N | 20105950 | FEC + DOCETAXEL |
| 20030079 | 20012822 | 1.7 | 67 | Adjuvant (A) | 2015-08-30 | 2015-08-31 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20105950 | FEC + DOCETAXEL |
| 20030080 | 20012823 | null | 78.5 | Neo-adjuvant (N) | 2015-11-17 | 2015-11-30 | FEC + DOCETAXEL | 02 | N | 20105955 | FEC + DOCETAXEL |
| 20030081 | 20072748 | 1.68 | 78 | Adjuvant (A) | 2017-06-13 | 2017-06-26 | FEC + DOCETAXEL | 02 | N | 20105957 | FEC + DOCETAXEL |
| 20030082 | 20012824 | 1.6 | 69 | Not known (9) | null | 2017-03-14 | FEC + DOCETAXEL | N | N | 20105965 | FEC + DOCETAXEL |
| 20030083 | 20012824 | 1.72 | 67.6 | Adjuvant (A) | 2015-03-03 | 2015-03-10 | FEC + DOCETAXEL | N | N | 20105965 | FEC + DOCETAXEL |
| 20030084 | 20012824 | null | null | Palliative (P) | 2015-09-19 | 2015-10-11 | FEC + DOCETAXEL | 2 | N | 20105965 | FEC + DOCETAXEL |
| 20030085 | 20012825 | null | 71 | Adjuvant (A) | null | 2015-04-07 | FEC 100 + DOCETAXEL | N | N | 20105970 | FEC + DOCETAXEL |
| 20030086 | 20012825 | 1.54 | 86.7 | Not known (9) | 2016-06-08 | 2016-06-21 | FEC + DOCETAXEL | 02 | null | 20105970 | FEC + DOCETAXEL |
| 20030087 | 20012826 | 1.59 | 81.4 | Adjuvant (A) | 2015-06-18 | 2015-06-18 | FEC + DOCETAXEL | N | N | 20105976 | FEC + DOCETAXEL |
| 20030088 | 20012827 | null | 74.4 | Adjuvant (A) | 2013-07-08 | 2013-07-29 | FEC 100 + DOCETAXEL | null | N | 20105977 | FEC + DOCETAXEL |
| 20030089 | 20012827 | 1.66 | 59.5 | Adjuvant (A) | 2015-11-21 | 2015-12-05 | FEC + DOCETAXEL | 02 | N | 20105977 | FEC + DOCETAXEL |
| 20030090 | 20012827 | null | null | Adjuvant (A) | 2017-08-25 | 2017-09-09 | FEC 100 + DOCETAXEL | null | null | 20105977 | FEC + DOCETAXEL |
| 20030091 | 20012828 | 1.67 | 74.1 | Adjuvant (A) | 2014-07-10 | 2014-07-22 | FEC + DOCETAXEL | 02 | N | 20105983 | FEC + DOCETAXEL |
| 20030092 | 20012828 | 1.57 | 49.7 | Neo-adjuvant (N) | 2017-07-29 | 2017-08-03 | FEC 100 + DOCETAXEL | 2 | N | 20105983 | FEC + DOCETAXEL |
| 20030093 | 20012828 | 1.58 | 77.4 | Adjuvant (A) | null | 2013-12-10 | FEC + DOCETAXEL | N | N | 20105983 | FEC + DOCETAXEL |
| 20030094 | 20012829 | 1.7 | 65.9 | Adjuvant (A) | null | 2016-12-03 | FEC + DOCETAXEL | N | N | 20106000 | FEC + DOCETAXEL |
| 20030095 | 20012829 | 1.64 | 69 | Adjuvant (A) | 2013-12-22 | 2014-01-05 | FEC + DOCETAXEL | N | N | 20106000 | FEC + DOCETAXEL |
| 20030096 | 20012829 | null | null | Adjuvant (A) | 2015-07-24 | 2015-08-21 | FEC + DOCETAXEL | N | N | 20106000 | FEC + DOCETAXEL |
| 20030097 | 20012830 | 1.55 | 76 | Adjuvant (A) | 2018-02-25 | 2018-03-14 | FEC + DOCETAXEL | 2 | N | 20106009 | FEC + DOCETAXEL |
| 20030098 | 20012830 | 1.63 | 54.5 | Adjuvant (A) | 2017-10-17 | 2017-11-06 | FEC + DOCETAXEL | 02 | N | 20106009 | FEC + DOCETAXEL |
| 20030099 | 20012830 | 1.7 | 66.6 | Disease modification (D) | 2014-03-31 | 2014-04-20 | FEC + DOCETAXEL | N | N | 20106009 | FEC + DOCETAXEL |
| 20030100 | 20012831 | 1.63 | 56 | Adjuvant (A) | 2013-10-11 | 2013-10-14 | FEC + DOCETAXEL | 02 | N | 20106013 | FEC + DOCETAXEL |